These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 24756811)

  • 1. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
    Kruper L; Xu X; Henderson K; Bernstein L
    Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.
    Hoskin TL; Hieken TJ; Degnim AC; Jakub JW; Jacobson SR; Boughey JC
    Surgery; 2016 Apr; 159(4):1199-209. PubMed ID: 26704783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
    Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
    Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
    Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
    Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
    Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
    Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
    Yao K; Stewart AK; Winchester DJ; Winchester DP
    Ann Surg Oncol; 2010 Oct; 17(10):2554-62. PubMed ID: 20461470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Patient Decisions About Breast Reconstruction After Mastectomy.
    Lee CN; Deal AM; Huh R; Ubel PA; Liu YJ; Blizard L; Hunt C; Pignone MP
    JAMA Surg; 2017 Aug; 152(8):741-748. PubMed ID: 28467530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.
    Patterson SG; Teller P; Iyengar R; Carlson GW; Gabram-Mendola SG; Losken A; Styblo T; Torres M; Wood WC; Perez SD; Mosunjac M; Rizzo M
    Ann Surg Oncol; 2012 Aug; 19(8):2679-84. PubMed ID: 22476750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
    Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
    Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors.
    Alderman AK; McMahon L; Wilkins EG
    Plast Reconstr Surg; 2003 Feb; 111(2):695-703; discussion 704-5. PubMed ID: 12560690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.